Effects of OK-432 Chemical Pleurodesis for Primary Spontaneous Pneumothorax: A Case-Control Study

preprint OA: closed CC-BY-4.0
📄 Open PDF View at publisher

Abstract

Background: Ipsilateral recurrence rate of primary spontaneous pneumothorax after video-assisted thoracoscopic surgery is higher than that after open surgery. This study aimed to evaluate the safety and efficacy of additional OK-432 pleurodesis after pleural abrasion for primary spontaneous pneumothorax patients. Methods This is a case-control study enrolling a total of 254 patients with primary spontaneous pneumothorax. 130 patients underwent blebs resection and pleural abrasion in the control group. 124 patients were enrolled in the OK-432 group, in which 1 Klinische Einheit of OK-432 was injected into thoracic cavity after surgery. Resuts : Patients demonstrated a trend of decreased rate of prolonged air leak in the OK-432 group (2.42% vs 19.23%, p  < 0.001). After a median follow-up of 36 months (range, 2–69 months), the rate of ipsilateral pneumothorax recurrence was lower in the OK-432 group than it in control group ( p  = 0.023). OK-432 pleurodesis is the most important factor reducing the risk of recurrence (relative risk: 0.13, 95% confidence interval (CI): 0.02 to 1.03)), and prolonged air leak patients had an increased risk of recurrence (relative risk: 11.69; 95% CI: 3.41 to 40.04). Conclusion OK-432 pleurodesis after pleural abrasion can reduce the risk of recurrence. OK-432 pleurodesis is a safe and effective method for reducing the rate of postoperative air leak and ipsilateral recurrence after thoracoscopic surgery.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-05-28T02:00:01.590549+00:00
License: CC-BY-4.0